Ironshore Pharmaceuticals Presents Pivotal Trial Data at American Psychiatric Association Meeting - SYS-CON Media (press release)

Ironshore Pharmaceuticals Presents Pivotal Trial Data at American Psychiatric Association MeetingSYS-CON Media (press release)Ironshore Pharmaceuticals & Development, Inc. (“Ironshore”), a wholly owned subsidiary of Highland Therapeutics Inc. and the global leader in the development of novel treatments for Attention-Deficit/Hyperactivity Disorder (“ADHD”), today announced ...and more »